The potency is guaranteed
Examine Race/Ethnicity Disparities in Perception, Intention, and Screening of Dementia in a Community Setting: Scoping Review
While clinical trials are ongoing, a study published in Alzheimers & Dementia in October 2024 found that people with Type 2 diabetes who used semaglutide (the active ingredient in Ozempic, Wegovy, and Rybelsus) had a lower risk of a first-time diagnosis of Alzheimers disease, compared to people who used insulin, other GLP-1s, or other diabetes medicines
Personalized Medication Management at PlexusDx PlexusDx prescribes compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan from licensed 503A compounding pharmacies, and all patients can add the Precision Peptide Genetic Test ($99) after their first month of treatment to understand their individual response patterns
It depends on the person
It is important to follow your healthcare providers guidance on when to contemplate stopping GLP-1 medication to ensure that the positive effects on your health are maintained in the long term